| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.34.6.1014 |
| P8608 | Fatcat ID | release_rp5vhkfiarft5paw6felv3rplq |
| P932 | PMC publication ID | 171748 |
| P698 | PubMed publication ID | 2393259 |
| P2093 | author name string | Kunz S | |
| Dworkin R | |||
| Modin G | |||
| Zak O | |||
| Rich R | |||
| Sande M | |||
| P2860 | cites work | In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs | Q35542064 |
| Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis | Q39724264 | ||
| Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus | Q39851078 | ||
| Model of experimental chronic osteomyelitis in rats | Q40167344 | ||
| Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. | Q40198546 | ||
| Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection | Q44299485 | ||
| Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. | Q54334088 | ||
| Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. | Q54408283 | ||
| Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases. | Q54494485 | ||
| Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents. | Q54494494 | ||
| Rifampin: Mechanisms of Action and Resistance | Q54495032 | ||
| Oral antibiotic therapy of skeletal infections in children | Q71168612 | ||
| Treatment of acute osteomyelitis in childhood | Q71596573 | ||
| Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin | Q71668173 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| rifampicin | Q422652 | ||
| vancomycin | Q424027 | ||
| methicillin-resistant Staphylococcus aureus | Q595158 | ||
| P304 | page(s) | 1014-1016 | |
| P577 | publication date | 1990-06-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis | |
| P478 | volume | 34 |
| Q41913615 | Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection |
| Q40891394 | Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? |
| Q37354361 | Antimicrobial therapy for bone and joint infections |
| Q44288521 | Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics |
| Q34107094 | Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus |
| Q35116767 | Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus |
| Q36757133 | Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers |
| Q36757117 | Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing |
| Q35165783 | Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis |
| Q35126785 | Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection |
| Q30446615 | Evaluation of quinolones in experimental animal models of infections |
| Q36409465 | Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. |
| Q35136601 | In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. |
| Q35897356 | Influence of rifampin on fleroxacin pharmacokinetics |
| Q36089510 | Local Intramedullary Delivery of Vancomycin Can Prevent the Development of Long Bone Staphylococcus aureus Infection |
| Q41340004 | Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up survey |
| Q34130045 | Monotherapy versus combination therapy for bacterial infections. |
| Q41891608 | Osteomyelitis management: More art than science? |
| Q36777850 | Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections |
| Q40633555 | Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance |
| Q40939719 | Quinolones and osteomyelitis: state-of-the-art. |
| Q40088846 | Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin |
| Q37672039 | Rifampin combination therapy for nonmycobacterial infections |
| Q33750776 | Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin |
| Q45216560 | Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment |
| Q36757553 | Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations |
| Q35810889 | Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics |
| Q35806369 | Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus |
| Q28714211 | Systemic antibiotic therapy for chronic osteomyelitis in adults |
| Q43741115 | Toxic effect of rifampicin on human osteoblast-like cells |
| Q42706257 | Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis |
| Q33179128 | Use of quinolones in osteomyelitis and infected orthopaedic prosthesis |
| Q34885043 | Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis |
Search more.